Daniel E. Oyon

408 total citations
11 papers, 283 citations indexed

About

Daniel E. Oyon is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Daniel E. Oyon has authored 11 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Daniel E. Oyon's work include Glioma Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (3 papers). Daniel E. Oyon is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (3 papers). Daniel E. Oyon collaborates with scholars based in United States, Philippines and Brazil. Daniel E. Oyon's co-authors include Orin Bloch, Joseph D. DiDomenico, Jonathan B. Lamano, Winward Choy, Leonel Ampie, Gurvinder Kaur, Dorina Veliceasa, Shayan Fakurnejad, Andrew T. Parsa and Yuping Li and has published in prestigious journals such as Clinical Cancer Research, Neuro-Oncology and OncoImmunology.

In The Last Decade

Daniel E. Oyon

8 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Oyon United States 5 153 123 101 66 42 11 283
Chujun Zhao China 6 145 0.9× 145 1.2× 45 0.4× 82 1.2× 48 1.1× 6 279
Hinda Najem United States 10 112 0.7× 61 0.5× 76 0.8× 92 1.4× 26 0.6× 23 244
Yinde Huang China 6 150 1.0× 156 1.3× 151 1.5× 99 1.5× 83 2.0× 21 372
Takahide Nejo Japan 12 71 0.5× 102 0.8× 84 0.8× 95 1.4× 43 1.0× 33 318
D. Schulz Germany 4 111 0.7× 58 0.5× 121 1.2× 136 2.1× 44 1.0× 5 335
Yong-Kil Hong South Korea 11 128 0.8× 134 1.1× 171 1.7× 149 2.3× 45 1.1× 22 409
Haitao Ge China 10 74 0.5× 90 0.7× 123 1.2× 111 1.7× 59 1.4× 23 326
Prajwal Rajappa United States 12 61 0.4× 77 0.6× 140 1.4× 62 0.9× 61 1.5× 31 263
Pia Sommerkamp Germany 7 242 1.6× 95 0.8× 63 0.6× 141 2.1× 15 0.4× 14 394

Countries citing papers authored by Daniel E. Oyon

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Oyon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Oyon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Oyon more than expected).

Fields of papers citing papers by Daniel E. Oyon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Oyon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Oyon. The network helps show where Daniel E. Oyon may publish in the future.

Co-authorship network of co-authors of Daniel E. Oyon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Oyon. A scholar is included among the top collaborators of Daniel E. Oyon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Oyon. Daniel E. Oyon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
3.
Oyon, Daniel E., et al.. (2023). Ventriculopleural shunt outcomes for pediatric hydrocephalus: a single-institution experience. Child s Nervous System. 39(8). 2105–2113. 3 indexed citations
4.
Oyon, Daniel E., et al.. (2022). Secondary CNS myeloma with remission after systemic CNS-penetrating agents. Neuro-Oncology Advances. 4(1). vdac106–vdac106.
5.
Lamano, Jonathan B., Joseph D. DiDomenico, Winward Choy, et al.. (2019). Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth. Clinical Cancer Research. 25(12). 3643–3657. 137 indexed citations
6.
Oyon, Daniel E., et al.. (2019). Robotic Tissue Manipulation and Resection in Spine Surgery. Neurosurgery Clinics of North America. 31(1). 121–129. 12 indexed citations
7.
DiDomenico, Joseph D., Winward Choy, Jonathan B. Lamano, et al.. (2018). Sellar plasmacytomas masquerading as pituitary adenomas: A systematic review. Journal of Clinical Neuroscience. 50. 20–23. 8 indexed citations
8.
DiDomenico, Joseph D., Jonathan B. Lamano, Daniel E. Oyon, et al.. (2018). The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma. OncoImmunology. 7(7). e1448329–e1448329. 96 indexed citations
9.
Lamano, Jonathan B., Winward Choy, Dorina Veliceasa, et al.. (2017). IMMU-38. GLIOBLASTOMA-DERIVED IL-6 INDUCES IMMUNOSUPPRESSIVE PERIPHERAL MYELOID CELL PD-L1 EXPRESSION AND TUMOR PROGRESSION. Neuro-Oncology. 19(suppl_6). vi120–vi121. 3 indexed citations
10.
Sayegh, Eli T., Tae-Min Oh, Shayan Fakurnejad, et al.. (2014). Principles of Surgery for Malignant Astrocytomas. Seminars in Oncology. 41(4). 523–531. 3 indexed citations
11.
Oh, Tae-Min, Eli T. Sayegh, Shayan Fakurnejad, et al.. (2014). Vaccine Therapies in Malignant Glioma. Current Neurology and Neuroscience Reports. 15(1). 508–508. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026